SCHEMBL54121

SCHEMBL54121

Nc1ccc(CO)cc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL864912 0.97 ALDH1A1 (0.55) —
SCHEMBL1309905 0.92 CYP3A4 (0.58) —
Bicarbonate SCHEMBL932925 0.89 TSHR (0.48) —
SCHEMBL18364910 0.85 ALDH1A1 (0.44) —
SCHEMBL15836247 0.85 MAPT (0.54) —
SCHEMBL23748641 0.85 LTA4H (0.65) —
SCHEMBL12973296 0.85 APP (0.58) —
SCHEMBL12653890 0.85 MAPT (0.64) —
SCHEMBL41775 0.83 TSHR (0.67) —
Aminobenzoic Acid SCHEMBL2107999 0.82 ALDH1A1 (0.52) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 9143 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122070936-A Nanometer material based on supermolecule polypeptide-drug coupling prodrug, and preparation method and application thereof 中国医学科学院生物医学工程研究所 2026-05-22 — — CN claimed
CN-122059976-A Double-lock cascade activated fluorescent probe and preparation method and application thereof 福州大学 2026-05-19 — — CN claimed
CN-121136277-B Modified polypropylene composite material for sealing head and preparation method thereof 滁州熙诚环保科技股份有限公司 2026-05-19 — — CN claimed
CN-122036842-A Cathepsin B-sensitive fatty acid-irinotecan prodrug and albumin nanoparticle thereof, and preparation method and application thereof 沈阳药科大学 2026-05-15 — — CN claimed
CN-122036845-A Cathepsin B-sensitive fatty acid-doxorubicin prodrug, albumin nanoparticle thereof, and preparation method and application thereof 沈阳药科大学 2026-05-15 — — CN claimed
US-20260124311-A1 POLYMER-DRUG CONJUGATES FOR STING PATHWAY ACTIVATION UNIV VANDERBILT (US) 2026-05-07 — — US claimed
EP-4036149-B1 HETEROBIFUNCTIONAL MONODISPERSED POLYETHYLENE GLYCOL HAVING PEPTIDE LINKER NOF CORP (JP) 2026-04-29 — — EP claimed
US-12605458-B2 Antibody-drug conjugate having acidic self-stabilization junction SYSTIMMUNE, INC. (US) 2026-04-21 — — US claimed
EP-3494996-B1 ANTIBODY DRUG CONJUGATES (ADC) THAT BIND TO 158P1D7 PROTEINS AGENSYS INC (US) 2026-04-15 — — EP claimed
US-20260083866-A1 COMPOSITIONS TARGETING ENDOTHELIAL CELLS AND USES THEREOF PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2026-03-26 — — US claimed
CN-1203615-A Laccases with improved dyeing properties NOVO NORDISK AS (DK) 1998-12-30 — — CN claimed
US-5795869-A IMMUNOLOGY AND PROTECTION AGAINST NEUROTOXICITY FOR NERVOUS SYSTEM DISORDERS FIDIA S.P.A. (IT) 1998-08-18 — — US claimed
JP-H08507308-A — — 1996-08-06 — — JP claimed
EP-0688331-A1 NEW SULFATED LYSO-GANGLIOSIDE DERIVATIVES FIDIA S.p.A. (IT) 1995-12-27 — — EP claimed
EP-0624377-A2 Lysosomal enzyme-cleavable antitumor drug conjugates Bristol-Myers Squibb Company (US) 1994-11-17 — — EP claimed
WO-1994020516-A1 NEW SULFATED LYSO-GANGLIOSIDE DERIVATIVES FIDIA S.P.A. (IT) 1994-09-15 — — WO claimed
EP-0038357-A4 HYDROLYTIC ENZYME-ACTIVATIBLE PRO-DRUGS. UNIV ILLINOIS (US) 1982-03-22 — — EP claimed
EP-0038357-A1 HYDROLYTIC ENZYME-ACTIVATIBLE PRO-DRUGS University of Illinois Foundation (US) 1981-10-28 — — EP claimed
WO-1981001145-A1 HYDROLYTIC ENZYME-ACTIVATIBLE PRO-DRUGS UNIV ILLINOIS (US) 1981-04-30 — — WO claimed
US-3931418-A Process for the production of insulating coatings on electrical conductors DR. KURT HERBERTS & CO. GESELLSCHAFT MIT BESCHRANKTER HAFTUNG VORM. OTTO LOUIS HERBERTS (DT) 1976-01-06 — — US claimed
Send feedback